Announcements Trials
Browse Landscape

Phase

Phase NA 43Phase 2 41Phase 1 23Phase 3 13Phase 4 7Phase 1/2 7Phase EARLY_PHASE1 5Phase 2/3 2

Status

Completed 5Recruiting 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Breast Neoplasms 97Prostatic Neoplasms 41Neoplasms 40Glioblastoma 26Melanoma 24Head and Neck Neoplasms 24Brain Neoplasms 24Ovarian Neoplasms 18Squamous Cell Carcinoma of Head and Neck 17Lung Neoplasms 17Carcinoma, Renal Cell 17Carcinoma, Hepatocellular 17Glioma 16Pancreatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Leukemia, Myeloid, Acute 14Colorectal Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Urinary Bladder Neoplasms 10Lymphoma 10Uterine Cervical Neoplasms 9Polycystic Ovary Syndrome 9Lymphoma, Non-Hodgkin 9Fallopian Tube Neoplasms 9Endometrial Neoplasms 9Myelodysplastic Syndromes 8Multiple Myeloma 8Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 8Skin Neoplasms 7

Interventions

Itraconazole 2Mohs Surgery 1HhAntag691 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Carcinoma, Basal Cell × Clear all
NCT04480645 2026-03-24

CivaDerm(TM) Surface Therapy Pilot Study

CivaTech Oncology

Phase EARLY_PHASE1 Completed
10 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT04279535 2021-11-02

Topical Vitamin C for Treatment of Basal Cell Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Completed
25 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT02120677 2020-12-16

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

Johns Hopkins University

Phase EARLY_PHASE1 Completed
5 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT02735356 2019-04-11

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Completed
9 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT01631331 2017-12-08

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

Stanford University

Phase EARLY_PHASE1 Completed
15 enrolled 10 charts
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡